BRAF and colorectal carcinoma: Several studies have shown that MSS BRAF‐mutated CRC have an aggressive phenotype (i.e., occurring at younger age, diagnosed at more advanced TNM stage, often poorly differentiated) and are associated with a poorer prognosis compared to MSI BRAF‐mutated CRC.20, 21